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Dendritic cells (DCs) form a bridge between the innate and
adaptive immune systems and fundamentally have an impact
on anti-infectious defense and immune-mediated diseases,
including those affecting the kidney. The field of renal
dendritic cells (rDCs) is rapidly evolving, and work in rodent
models has provided the first insight into their functional role
in kidney homeostasis and disease. Recent findings indicate
that rDCs have an important sentinel role against kidney
injury and infection. In acute immune-mediated disease they
function in an anti-inflammatory manner, but may acquire
pro-inflammatory functionality when renal inflammation
becomes chronic. In chronic disease rDCs mature and
stimulate rather than tolerize effector T cells, and may
contribute to progression of kidney disease. Recent progress
in aligning murine and human DC subsets has opened
avenues for making knowledge obtained from mechanistic
studies in animal models available for better interpretation
of kidney biopsies. There is firsthand evidence indicating
changes in human DC subsets and their distribution in some
kidney diseases. Data are presently lacking on the identity of
rDC progenitors, the molecular mechanisms governing their
recruitment into the kidney, and the role of rDCs in kidney
homeostasis. This review highlights recent findings in the
study of rDCs.
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Dendritic cells (DCs) are constituents of the mononuclear
phagocytic system present in all tissues,1,2 including the
kidney.3 There they take up antigens and transport them to
draining lymph nodes, in order to present them to naive
T cells.4 In the absence of pathogen-associated molecular
patterns, such as lipopolysaccharides from Gram-negative
bacteria, DCs tolerize T cells, whereas the presence of such
patterns causes them to induce adaptive immunity by driving
the development of effector T cells.1,2 Such T cells then enter
tissues to combat pathogens, and may be further regulated by
tissue-resident DCs. Tissue DCs have recently been shown to
also affect organ homeostasis, the surveillance of pathogens,
and the induction of innate immunity.2,5 There is overlap
between the definitions of DCs and macrophages.
As a rule of thumb, we consider macrophages as cells with
intrinsic immune effector function and DCs as instructors
of immune effector cells, especially T cells.
Renal DCs (rDCs) can be identified in mice by co-
expression of CD11c and major histocompatibility complex
class II,3 whereas human DCs require the use of additional
parameters for identification, such as blood dendritic cell
antigen (BDCA) markers, C-type lectins such as DEC-205,
langerin (CD207), or DC-SIGN (CD209), and recently also
chemokine receptors such as XCR1 (ref. 6). These markers
have allowed defining multiple subsets with differing
functionality by flow cytometry. However, there is no
generally accepted classification system of DC subsets at
present.4 On the other hand, the necessity to combine several
markers has hampered studies on human kidney sections, in
which combining markers is more difficult.
In the mature kidney, rDCs form an extensive paren-
chymal network that spans the entire tubulointerstitium,
enclosing all nephrons, ensuring complete surveillance of this
organ.7 Although rDCs are remarkably abundant, their role
in homeostasis and disease is just beginning to emerge.8,9
Their role in the human kidney, in both homeostasis and
disease, is still largely unknown. Recent studies showing
alterations of rDC populations in common renal diseases
support an involvement.10–12
In this review, we summarize the current knowledge on
the homeostatic and pathogenic roles of renal DCs. Areas
focused on include their development, a comparison between
subsets in humans and mice, and the role of rDCs in kidney
disease.
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ORIGIN OF RENAL DENDRITIC CELLS
Bone marrow-derived progenitors
Tissue DCs are generally derived from ‘macrophage and DC
precursors’ (MDPs) in the bone marrow, which differentiate
either into monocytes or into ‘common DC precursors’ . The
common DC precursors give rise to migratory pre-DCs
and plasmacytoid DCs, a process which has recently been
reviewed elsewhere.2,13 Two subsets of monocytes have been
discriminated, the Ly6Cþ inflammatory monocytes and
Ly6C– ‘patrolling’ monocytes.2 Both of these subsets have
been demonstrated to be recruited into the inflamed
kidney.14 Candidates for the precursors of rDCs in the steady
state include Ly6C– monocytes and the pre-DCs (Figure 1).
Pre-DCs occur at frequencies between 0.02–0.05% in blood,
spleen, and lymphatic organs,13 and can principally give rise
to rDCs, as shown by adoptive transfer experiments.15
Having only recently been identified, factors that regulate
the differentiation and migration of renal DC progenitors,
and their relative contribution to establishing the renal DC
network are yet to be fully elucidated.
Migration and differentiation
Chemokine receptors efficiently guide DC precursors into
both healthy and inflamed organs. The expression of CCR1,
CCR2, CCR5, CX3CR1, and CCR7 has been demonstrated on
rDCs, and specifically CCR5 contributed to their entry into
the healthy kidney16 (Figure 1). Murine rDCs have a turnover
of about 14 days in homeostasis.17 Although yet poorly
understood for the kidney, evidence from other organs
suggests that under inflammatory conditions, rDCs may
originate from Ly6Cþ blood monocytes.18 Their immigra-
tion into the injured kidney has been shown to be mediated
by the chemokine receptors CCR2 and CX3CR1 (ref. 14).
If the chemokine receptors differed between precursors
of anti- and pro-inflammatory DCs, then this might be
therapeutically exploited.
The development of DCs depends on the growth factors
Fms-like tyrosine kinase 3 ligand, colony stimulating factor 1,
and granulocyte macrophage-colony stimulating factor.4,15
These factors regulate DC homeostasis in both the bone
marrow and periphery, and granulocyte macrophage-colony
stimulating factor has been shown to be expressed by kidney
tubular cells.9 However, the introduction of this growth
factor into the kidney initiated renal injury,19 illustrating that
the roles of these factors in the kidney are more complex than
previously thought.
After administration of lipopolysaccharide as a model for
an infectious challenge, there was a decrease of DC numbers
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Figure 1 | Life cycle of renal dendritic cells (DCs). Different bone marrow-derived progenitors are released to the circulation and enter
the kidney in homeostasis and inflammation, presumably using different mechanisms. They differentiate into renal DCs and some later
migrate to the renal lymph nodes, in order to present the antigen to T cells. CDP, common DC precursor; MDP, monocyte, macrophage,
and DC precursor; MO, monocytes; pDC, plasmacytoid DC; pre-DCs, pre-classical DCs.
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in the kidney and an increase in the renal lymph nodes,20
suggesting their migration, in agreement with the canonical
life cycle of DCs (Figure 1). Lipopolysaccharide injection
downregulated CCR1 and CCR5, and upregulated CCR7 on
rDCs,16 which may be mechanistically relevant, because work
in other organs has demonstrated that CCR7 expression by
DCs, and of its ligands CCL19 and CCL21 in lymphatic
vessels, is a requirement for DC relocation to draining lymph
nodes. However, formal evidence for DC migration from the
kidney to the renal lymph node is lacking.
Renal DC subsets in homeostasis
Many different subsets of DCs have been described, and
various classification systems have been proposed that
significantly overlap.4 A simplified model of DC subsets in
mice and humans has recently been suggested.21 According to
that nomenclature, the majority of DCs in non-lymphoid
tissues, including the kidney, belong to the CD11b-like
subset, which in other systems are referred to as ‘myeloid
DCs’, ‘classical CD8-negative’, or ‘conventional CD8-negative
DCs’.1,4,6 In non-lymphoid tissues, such DCs generally also
express the fractalkine receptor CX3CR1, CD11b, F4/80, and
major histocompatibility complex II.1,2 This is true also for
rDCs.3,7 The fact that CD11b and especially F4/80 are
expressed by tissue DCs is not generally known, and therefore
these markers are often considered to be specific for
macrophages, perhaps because F4/80 is reasonably specific
for macrophages in the spleen, from which many paradigms
about mononuclear phagocytes have been extrapolated to
other organs. Complexity is increased by phenotypic
variability, as about 10–15% of the rDCs express CD11b,
but lack F4/80, and B5–10% of the rDCs lack both markers,
but express CD103 (ref. 15), which would place them into the
CD8-like DC subset, which is functionally distinguished by
the ability to cross-present antigens to CD8þ T cells.1,6 The
role of these DC subsets in the healthy and diseased kidney is
unknown.
Moreover, studies on human kidney biopsies have
described DCs of the CD11b-like subset,10 which in humans
is characterized by expression of the BDCA-1 marker.21 Some
of these DCs co-expressed the lectin DC-SIGN and CD68, the
latter of which is sometimes used as a macrophage marker,
like F4/80. Notably, about 20% of the DCs expressed BDCA-2
(ref. 10). This is a marker for human plasmacytoid DCs,21 the
main function of which is the production of type I interferon
in response to viral infection. Murine rDCs lack phenotypic
markers for plasmacytoid DCs, and evidence for type I
interferon production by rDCs is lacking in both mice and
men.
FUNCTIONALITY OF RENAL DENDRITIC CELLS
Uptake and tolerance to filtered antigen in homeostasis
Work in animal models showed that the antigens captured by
DCs within the kidney include tubular9,17 and glomerular5
autoantigens, proteins injected into the kidney,22 and small-
molecular-weight antigens that are constitutively filtered in
the glomeruli23 (Figure 2). DCs in the renal lymph node also
gain access to such antigens, but this does not necessarily
occur by migration from the kidney, but may also result from
lymphatic bulk drainage and uptake by lymph node-resident
DCs. In the absence of pathogen-associated molecular
patterns or other ‘danger signals’, these resident DCs tolerized
T cells against antigens that had been filtered in the kidney.23
This tolerance mechanism may be important for preventing
unwanted immunity against food-derived antigens or small-
molecular-weight self-antigens that are produced intermit-
tently, for example certain hormones, which are not readily
available in the thymus for efficient negative selection of
autoreactive T cells. Thus, the kidney may contribute to
maintaining peripheral immune tolerance against such
innocuous antigens, but this remains to be formally
demonstrated.
Other possible functions of rDCs in homeostasis
Little is known about the function of rDCs under homeo-
static conditions. Roles for mononuclear phagocytic cells,
such as DCs and macrophages, are currently being theorized
and may include the clearance of apoptotic cells and
regulation of uretic branching and nephron development in
nephrogenesis.8 Research presented at the 2010 meeting of
the American Society of Nephrology points toward homeo-
static roles of rDCs resulting from direct interaction with
intrinsic kidney cells, such as tubular epithelial cells and
podocytes. In addition, cross-talk between rDCs and
mesenchymal stem cells seems to have anti-inflammatory
consequences.24 Furthermore, the intrarenal induction of
regulatory T cells by rDCs seems possible.
Anti-inflammatory roles in acute kidney disease
Nephrotoxic nephritis (NTN) is a widely used mouse model
for human crescentic glomerulonephritis, and results from a
CD4þ T helper (Th) cell-dependent intrarenal delayed-type
hypersensitivity reaction.25 When DCs were depleted using
CD11c-DTR mice in the acute phase of NTN (day 4 until day 7
after disease induction), disease was aggravated. This indicated
that rDCs functioned in a protective manner, possibly because
of increased expression of the inhibitory molecule inducible
T-cell costimulator ligand and the induction of interleukin-10
(IL-10) production by Th cells, and possibly also by rDCs
themselves.26 Both inducible T-cell costimulator ligand and
IL-10 have been shown to attenuate NTN.9,25,27
rDCs have also been shown to attenuate cisplatin
nephrotoxicity, again by mechanisms involving upregulated
expression of inducible T-cell costimulator ligand and
IL-10 secretion.28
DCs additionally influenced ischemia reperfusion injury, a
major obstacle in kidney transplantation. Damage is
mediated by infiltrating neutrophils and pro-inflammatory
monocytes that use CCR2 and CX3CR1 to enter the ischemic
kidney.14 rDCs were the earliest producers of tumor necrosis
factor a and other pro-inflammatory cytokines such as IL-6,
monocyte chemotactic protein-1, and RANTES,29 suggesting
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a contribution to kidney injury. Recently it has been shown
that interferon regulatory factor 4 attenuates the expression
of these pro-inflammatory molecules in CD11cþ cells, thus
preventing excess ischemic tissue damage.30 However, rDCs
may also contribute to the recovery process through
increased IL-10 production.31 In support of this, DCs were
protective both in ischemic pre-conditioning32 and after
induction of ischemia reperfusion injury,31 indicating the
beneficial functionality of DCs.
The immune-tolerizing and anti-inflammatory properties
of DCs may thus have therapeutic potential, as demonstrated
by studies showing that the transfusion of functionally
immature donor rDCs after renal transplantation prolongs
graft survival.27
Pro-inflammatory role in chronic kidney disease
In models of more chronic kidney disease, pathogenic roles
have been attributed to rDCs (Figure 2). DCs matured during
the course of NTN and provided more co-stimulatory
molecules and pro-inflammatory cytokines to Th1 effector
cells.33 Furthermore, the proteinuria that characteristically
occurs in NTN enabled rDCs to capture more filterable
antigen and antigens too large to pass through the glomerular
filter in healthy mice, so that such antigens could be
presented to Th cells in an immunogenic manner.33 Notably,
the expression of IL-10 increased with disease progression
but was no longer protective, suggesting that the induction of
pro-inflammatory mediators prevailed at later disease stages.
A link between proteinuria, immune cells, and disease
progression was proposed also in the rat 5/6 nephrectomy
model, where rDCs processed self-antigens like albumin,
which pass through the glomerular filter only under
proteinuric conditions, to antigenic peptides.34 Taken
together, these findings suggest a novel mechanism by which
proteinuria may be nephrotoxic, by supplying DCs with
more and different antigens that may stimulate pathogenic
Th1 cells to cause kidney injury.
A pathogenic role for rDCs had been demonstrated also in
a murine model of T-cell-mediated glomerular injury, which
used the expression of model antigens like ovalbumin by
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glomerular podocytes.5 The co-injection of ovalbumin-
specific CD8þ and CD4þ T cells resulted in periglomerular
mononuclear infiltrates (monocyte-derived macrophages and
DCs, T cells) and parietal epithelial cell inflammation, which
was reminiscent of rapid progressive forms of human
glomerulonephritis. Mechanistically, rDCs captured glomer-
ular antigens released by CD8þ T cells and presented them to
CD4þ T cells, causing the production of pro-inflammatory
cytokines and chemokines like IL-12, interferon-g, tumor
necrosis factor a and CCR5 ligands. In this way, cross-talk
between rDCs and Th1 cells maintained tubulointerstitial
infiltration and caused progressive kidney damage.5 These
findings suggest that presentation of glomerular antigen by
DCs located in the tubulointerstitium may be a mechanism
of glomerulonephritis progression, and may explain why such
progression is closely correlated with tubulointerstitial, rather
than glomerular infiltration.9
A role for DCs in disease progression was recently
described in lupus nephritis,35 the only disease in which
DCs, notably including plasmacytoid DCs, have been found
to infiltrate glomeruli.36 Again, kidney DCs produced IL-12
and induced a pro-inflammatory microenvironment within
the kidney.37 In various mouse models of lupus nephritis,
tubulointerstitial rDCs were increased in numbers and
attracted and activated lymphocytes,36 using chemokines
such as CXCL-13 (ref. 38). A role in the progression, rather
than the initiation, of mononuclear interstitial infiltrates was
seen also in lupus.35 rDCs also expressed pro-inflammatory
danger molecules such as high-mobility group box protein
that favor immunogenic responses.39 Additional studies to
directly address the role of rDCs in models of this form of
nephritis are necessary.
Chronic kidney inflammation is closely correlated with the
development of fibrosis. In the commonly used unilateral
ureter obstruction model of kidney fibrosis, rDCs produced
tumor necrosis factor a and induced IL-17 and interferon-g
expression in CD4þ T cells.40 The depletion of mononuclear
phagocytes by clodronate liposomes reduced the production of
pro-inflammatory cytokines and the amount of fibrotic tissue
and delayed the loss of renal function.40,41 However, this
depletion method is not specific for DCs, but for all F4/80þ
cells, including macrophages.41 And in fact, when the same
group used CD11c-DTR mice to specifically deplete DCs, it
became clear that macrophages and not DCs promoted fibrosis
in unilateral ureter obstruction,42 highlighting the need for
tools that discriminate between DCs and macrophages.
Finally, DCs are indirectly required for antibody produc-
tion, because of their role in activating Th cells. This function
implies an involvement also in antibody- or immune-
complex-mediated diseases affecting the kidney, including
forms of anti-neutrophil cytoplasmic antibodies-associated
vasculitis such as Wegner’s granulomatosis. In this disease,
proteinase-3-specific autoantibodies are present, and pro-
teinase-3 has been shown to cause maturation of blood
monocyte-derived immature DCs, which rendered them
competent for activating specific Th cells.43 A similar role
in other anti-neutrophil cytoplasmic antibodies-associated
vasculitis forms that involve autoantibodies against myelo-
peroxidase or LAMP2 seems conceivable.
Anti-infectious role in pyelonephritis
Little is known about the role of rDCs in the clearance and
recognition of infectious pathogens from the kidney. The
most relevant renal infection is bacterial pyelonephritis,
which is usually due to ascending uropathogenic Escherichia
coli, and may become chronic and result in end-stage renal
disease. The innate immune response is known to involve
TLR4 signalling by hematopoietic cells, the chemokine
CXCL-2 and neutrophilic granulocytes. We have recently
observed in a murine model of pyelonephritis that rDCs were
the earliest cells to produce CXCL-2 and were required for
rapid recruitment of neutrophils.44 This finding suggests that
rDCs have a sentinel role against kidney infections.
Dendritic cell subsets in renal disease
The composition of DC subsets did not seem to change in
models of renal disease where subsets were examined, with
the exception of recruitment of Ly6Cþ inflammatory DCs.5
In human kidney disease, only few studies on DC subsets are
available. The differences between mouse and human DC
subset markers (see Table 1) have added to the uncertainty. A
cross-sectional analysis of DCs in diseased kidneys, including
transplant rejection and IgA nephropathy, revealed that the
number of DCs as well as their anatomical distribution
changed under pathophysiological conditions.10 Several
biopsy-based studies have demonstrated the presence of
DC-SIGN (CD209)-positive cells in the tubulointerstitium,
which is increased in disease, especially in periglomerular
areas. Both DC-SIGNþ DCs and BDCA-2þ plasmacytoid
DCs have been noted.10 However, there are conflicting data
on the presence of DCs in the glomerular mesangium,10,11
and on whether DC-SIGNþ cell numbers correlate with
disease severity. Mice possess at least eight DC-SIGN
paralogs, of which the expression pattern and functional
relation to human DC-SIGN is unclear, so this molecule is
not routinely used for DC classification in mice. Clearly,
better mechanistic understanding of DC subsets in nephritis
models and larger studies on DC subsets in kidney biopsies
are warranted. Current attempts by immunologists to
align the DC subset terminology in murine and human
systems1,2,4,13,21 may allow connecting the mechanistic and
epidemiological information obtained in these systems.
CONCLUDING REMARKS
Kidney research has recently turned attention toward the
extensive network of rDCs within the tubulointerstitium.
Animal models have provided a number of fundamental
discoveries in this rapidly moving field, which are summar-
ized in Box 1. These include the homeostatic phenotype of
rDCs, sentinel roles against pathogens, and anti-inflamma-
tory functions in models of acute renal injury. Such beneficial
functions may be subverted in chronic disease, where DCs
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mature and become pro-inflammatory. The precise molecu-
lar control of this process has still to be determined, before
clinical translation becomes possible. This and further
current challenges on the long road toward translation are
summarized in Box 2. Although the currently available data
provide an insight into the origin, differentiation, and
function of rDCs, there is still much to learn, both under
homeostatic conditions and in disease. Addressing these
challenges, particularly closing the gap in knowledge and
terminology regarding human and murine rDCs, will open
new diagnostic opportunities and may even allow the
development of novel therapies.
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